IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ARBEW

Balance Sheet

(in millions USD)
MetricQ3 2025Q2 2025Q1 2025Q3 2024Q3 2022
Cash & Equivalents4.016.606.9018.7963.36
Short-term Investments48.31------0.40
Accounts Receivable0.380.280.060.62--
Total Current Assets63.6037.3846.8852.2467.34
Property, Plant & Equipment1.211.231.271.431.68
Total Non-current Assets2.4938.4538.163.232.22
Total Assets66.0875.8385.0455.4769.56
Short-term Debt--------4.92
Total Current Liabilities15.2116.0017.8036.277.14
Total Non-current Liabilities1.761.851.521.985.07
Total Liabilities*16.9817.8519.3238.2512.21
Retained Earnings(287.97)(276.93)(266.77)(240.76)(149.03)
Total Stockholder Equity49.1157.9965.7217.2157.35
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2025Q2 2025Q1 2025Q3 2024Q3 2022
Total Revenue0.570.270.040.673.37
Cost of Revenue0.500.460.341.251.07
Gross Profit(0.24)(0.18)(0.30)(0.58)2.30
Research & Development8.258.229.6926.0725.90
Selling, General & Admin1.781.781.995.936.59
Total Operating Expenses11.2711.3013.0636.2435.92
Operating Income(11.51)(11.48)(13.36)(36.82)(33.62)
Net Income(11.03)(10.16)(13.82)(37.12)(29.38)
Basic EPS(0.10)(0.09)(0.13)(0.46)(0.46)
Diluted EPS(0.10)(0.09)(0.13)(0.58)(0.46)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2025Q2 2025Q1 2025Q3 2024Q3 2022
Operating Cash Flow(11.15)(11.78)(6.22)(24.28)(31.65)
Capital Expenditures0.150.060.030.530.58
Free Cash Flow*(11.30)(11.83)(6.25)(24.81)(32.23)
Investing Cash Flow8.3910.78(53.20)14.85(0.98)
Financing Cash Flow0.190.0053.39(0.25)(4.95)
← Scroll for more columns →

* Derived from reported values